NASDAQ · Biotechnology
Ardelyx Inc (ARDX)
$2.99
-2.29%
46
In band
Moving averages
SMA 200$5.18-42.28%
Company profile
Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California.
SectorHealthcare
IndustryBiotechnology
Market cap$786.80M
P/E ratioNone
EPS$-0.23
Beta0.769
Dividend yield0.00%
52-week high$8.40
52-week low$2.80
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
CADL
Candel Therapeutics Inc
RSI 27
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 40
CAPR
Capricor Therapeutics Inc
RSI 49
GERN
Geron Corp
RSI 44
ANRO
Alto Neuroscience Inc
RSI 52
GHRS
GH Research PLC
RSI 41
RSI alerts for ARDX
An email when ARDX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 4:31 AM EST